Asset Prioritization

Develop R&D strategy with reliable analysis of your asset group and come up focused list of prioritized assets.
Request for proposal
Any company’s bundle of assets are of vital importance to them. What needs to be assessed is how important they can become in a clinical setting, and how much these assets might lead to a sizeable return on investment to the company.

Our Perspective

DelveInsight’s Asset Prioritization methodology employs intuitive assessments to initiate the client’s R&D journey. DelveInsight’s analysts work with the client team to develop intelligent criteria, create assessment scenarios through reliable parameters of importance and define situations for consequence of possible successes and failures. Our Asset Prioritization service provides understanding future market dynamics through market modelling, unmet medical needs for future understanding of treatment regimens, and thus, help create a sound strategy for company’s research and development.
Our Asset Prioritization methodology provides:

Insights

Assest prioritization study

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation [...]

Epidemiology Assessment study

Epidemiology Assessment

A client based in the US wanted the epidemiology assessment exercise to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma... [...]

Portfolio Management study

Portfolio Management

A small-Pharma client based in Israel involved DelveInsight to manage their portfolio of candidates indicated for various infectious diseases. [...]

Due Diligence study

Due Diligence

A medium pharmaceutical client with capabilities in novel formulations was involved in a deal with a manufacturing company for commercial-scale manufacturing of the client’s therapies. [...]

Request For Proposal

*I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.